Fatty liver largely explains associations of subclinical hypothyroidism with insulin resistance, metabolic syndrome, and subclinical coronary atherosclerosis

European Journal of Endocrinology

Volumn 171, Issue 3, 2014, Pages 319-325

  Posadas Romero, Carlos ^a   Jorge Galarza, Esteban ^a   Posadas Sánchez, Rosalinda ^a   Acuña Valerio, Jorge ^a   Juárez Rojas, Juan G ^a   Kimura Hayama, Eric ^a   Medina Urrutia, Aida ^a   Cardoso Saldaña, Guillermo C ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY WEIGHT; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; EUTHYROIDISM; FATTY LIVER; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RISK ASSESSMENT; RISK FACTOR; SUBCLINICAL HYPOTHYROIDISM; BLOOD; CORONARY ARTERY DISEASE; HYPOTHYROIDISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; HUMANS; HYPOTHYROIDISM; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 84907200340     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0150     Document Type: Article

References (41)

1. Cooper DS & Biondi B. Subclinical thyroid disease. Lancet 2012 379 1142-1154. (doi:10.1016/S0140-6736(11)60276-6)
2. Stefan N, Kantartzis K & Häring H-U. Causes and metabolic consequences of fatty liver. Endocrine Reviews 2008 29 939-960. (doi:10.1210/er.2008-0009)
3. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM & Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004 40 1387-1395. (doi:10.1002/hep.20466)
4. Korenblat KM, Fabbrini E, Mohammed BS & Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008 134 1369-1375. (doi:10.1053/j.gastro.2008.01.075)
5. Ginsberg HN, Zhang YL & Hernandez-Ono A. Metabolic syndrome: focus on dyslipidemia. Obesity 2006 14 (Suppl 1) 41S-49S. (doi:10.1038/oby.2006.281)
6. Assy N, Djibre A, Farah R, Grosovski M & Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010 254 393-400. (doi:10.1148/radiol.09090769)
7. Pacifico L, Bonci E, Ferraro F, Andreoli G, Bascetta S & Chiesa C. Hepatic steatosis and thyroid function tests in overweight and obese children. International Journal of Endocrinology 2013 2013 1-8. (doi:10.1155/2013/381014)
8. Maratou E, Hadjidakis DJ, Kollias A, Tsegka K, Peppa M, Alevizaki M, Mitrou P, Lambadiari V, Boutati E, Nikzas D et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. European Journal of Endocrinology 2009 160 785-790. (doi:10.1530/EJE-08-0797)
9. Chung GE, Kim D, Kim W, Yim JY, Park MJ, Kim YJ, Yoon JH & Lee HS. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. Journal of Hepatology 2012 57 150-156. (doi:10.1016/j.jhep.2012.02.027)
10. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P & Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine 2005 165 2467-2472. (doi:10.1001/archinte.165.21.2467)
11. Razvi S, Weaver JU, Vanderpump MP & Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of theWhickhamSurvey cohort. Journal of Clinical Endocrinology and Metabolism 2010 95 1734-1740. (doi:10.1210/jc.2009-1749)
12. Chen G, Wu J, Lin Y, Huang B, Yao J, Jiang Q, Wen J & Lin L. Associations between cardiovascular risk, insulin resistance, b-cell function and thyroid dysfunction: a cross-sectional study in She ethnic minority group of Fujian Province in China. European Journal of Endocrinology 2010 163 775-782. (doi:10.1530/EJE-10-0710)
13. Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay- Sevilla ME, Malacara JM et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. European Journal of Endocrinology 2010 163 273-278. (doi:10.1530/EJE-10-0312)
14. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP & Ladensos PW. Thyroid status, cardiovascular risk, and mortality in older adults. Journal of the American Medical Association 2006 295 1033-1041. (doi:10.1001/jama.295.9.1033)
15. Ittermann T, Haring R, Wallaschofski H, Baumeister SE, Nauck M, Dörr M, Lerch MM, Meyer zu Schwabedissen HE, Rosskopf D & Völzke H. Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. Thyroid 2012 22 568-574. (doi:10.1089/thy.2011.0279)
16. Pagadala MR, Zein CO, Dasarathy S, Yerian LM, Lopez R & McCullough AJ. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Digestive Diseases and Sciences 2012 57 528-534. (doi:10.1007/s10620-011-2006-2)
17. Villarreal-Molina T, Posadas-Romero C, Romero-Hidalgo S, Antúnez- Argüelles E, Bautista-Grande A, Vargas-Alarcón G, Kimura-Hayama E, Canizales-Quinteros S, Juárez-Rojas JG, Posadas-Sánchez R et al. The ABCA1 gene R230C variant is associatedwith decreased risk of premature coronary artery disease: the genetics of atherosclerotic disease (GEA) study. PLoS ONE 2012 7 e49285. (doi:10.1371/journal.pone.0049285)
18. McKimmie RL, Daniel KR, Carr JJ, BowdenDW, Freedman BI, RegisterTC, Hsu FC, Lohman KK, Weinberg RB & Wagenknecht LE. Hepatic steatosis and sub-clinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study. American Journal of Gastroenterology 2008 103 3029-3035. (doi:10.1111/j.1572-0241.2008.02188.x)
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Donato KA, Eckel RH, Franklin BA, Gordon DJ et al. American Heart Association; National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 2735-2752. (doi:10.1161/CIRCULATIONAHA.105. 169404)
20. Sánchez-Castillo CP, Velázquez-Monroy O, Berber A, Lara-Esqueda A, Tapia-Conyer R & James WP. Anthropometric cutoff points for predicting chronic diseases in the Mexican National Health Survey 2000. Obesity Research 2003 11 442-451. (doi:10.1038/oby.2003.60)
21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009; 32: s62-s67. (doi:10.2337/dc09-S062)
22. DeLong DM, DeLong ER, Wood PD, Lippel K & Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol. The Lipid Research Clinics Prevalence Study. Journal of the American Medical Association 1986 256 2372-2377. (doi:10.1001/jama.1986.03380170088024)
23. Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP, Ladenson PW, Vittinghoff E, Gottdiener JS & Newman AB. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. Journal of the American College of Cardiology 2008 52 1152-1159. (doi:10.1016/j.jacc.2008.07.009)
24. Rodondi N, Den Elzen WPJ, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. Journal of the American Medical Association 2010 304 1365-1374. (doi:10.1001/jama.2010.1361)
25. Nanchen D, Gussekloo J, Westendorp RG, Stott DJ, Jukema JW, Trompet S, Ford I, Welsh P, Sattar N, Macfarlane PW et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2012 97 852-861. (doi:10.1210/jc.2011-1978)
26. Kvist H, Chowdhury B, Grangard U, Tylén U & Sjöström L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adultmen and women: predictive equations. American Journal of Clinical Nutrition 1988 48 1351-1361.
27. Longo R, Ricci C, Masutti F, Vidimari R, CrocéLS, Bercich L, Tiribelli C & Dalla Palma L. Fatty infiltration of the liver. Quantification by 1H localized magnetic resonance spectroscopy and comparison with computed tomography. Investigative Radiology 1993 28 297-302. (doi:10.1097/00004424-199304000-00006)
28. Mautner GC, Mautner SL, Froehlich J, Feuerstein IM, Proschan MA, Roberts WC & Doppman JL. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology 1994 192 619-623. (doi:10.1148/radiology.192.3.8058924)
29. Knudsen N, Laurberg P, Rasmussen LB, Bülow I, Perrild H, Ovesen L & Jørgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. Journal of Clinical Endocrinology and Metabolism 2005 90 4019-4024. (doi:10.1210/jc.2004-2225)
30. Nyrnes A, Jorde R & Sundsfjord J. Serum TSH is positively associated with BMI. International Journal of Obesity 2006 30 100-105. (doi:10.1038/sj.ijo.0803112)
31. Sundaram V, Hanna AN, Koneru L, Newman HA & Falko JM. Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation. Journal of Clinical Endocrinology and Metabolism 1997 82 3421-3424. (doi:10.1210/jcem.82.10.4315)
32. Poli G, Albano E & Dianzani MU. The role of lipid peroxidation in liver damage. Chemistry and Physics of Lipids 1987 45 117-142. (doi:10.1016/0009-3084(87)90063-6)
33. Tièche M, Lupi GA, Gutzwiller F, Grob PJ, Studer H & Bürgi H. Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease? British Heart Journal 1981 46 202-206. (doi:10.1136/hrt.46.2.202)
34. Imaizumi M, Akahoshi M, Ichimaru S, Nakashima E, Hida A, Soda M, Usa T, Ashizawa K, Yokoyama N, Maeda R et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. Journal of Clinical Endocrinology and Metabolism 2004 89 3365-3370. (doi:10.1210/jc.2003-031089)
35. Sert A, Pirgon O, Aypar E, Yilmaz H & Odabas D. Subclinical hypothyroidismas a risk factor for the development of cardiovascular disease inobese adolescents withnonalcoholic fatty liver disease. Pediatric Cardiology 2013 34 1166-1174. (doi:10.1007/s00246-013-0638-z)
36. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, Hirschhorn JN, O'Donnell CJ & Fox CS. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010 51 1979-1987. (doi:10.1002/hep.23593)
37. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A & Klein S. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. PNAS 2009 106 15430-15435. (doi:10.1073/pnas.0904944106)
38. Liu J, Musani SK, Bidulescu A, Carr JJ, Wilson JG, Taylor HA & Fox CS. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis 2012 224 521-525. (doi:10.1016/j.atherosclerosis.2012.07.042)
39. Sung KC, Wild SH, Kwag HJ & Byrne CD. Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10, 153 people. Diabetes Care 2012 35 2359-2364. (doi:10.2337/dc12-0515)
40. Limanond P, Raman SS, Lassman C, Sayre J, Ghobrial RM, Busuttil RW, Saab S & Lu DS. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004 230 276-280. (doi:10.1148/radiol. 2301021176)
41. Bonora E, Targher G & Alberiche M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000 23 57-63. (doi:10.2337/diacare.23.1.57)